Dana Kristjansson, MD PhD
Research Background: Cancer, fertility, aging
I’m Dana Kristjansson, an epidemiologist in Oslo, Norway with a focus on fertility, cancer, and mitochondrial DNA. My work is focused on leveraging the plethora of data available in Norway to identify causes of disease. I collaborate with other scientists to draw on interdisciplinary expertise and consolidate data from other populations. On this site, you’ll find my virtual portfolio of scientific work. Whether you’re a colleague, a collaborator, or just curious, welcome!
My work focuses on the impact of modifiable exposure on chronic disease outcomes in later life, and makes use of a broad and comprehensive background in tumor biology, aging, and preventive medicine. I am an MD, having conducted internal medicine training at New York Presbyterian Hospital, which inspires me to ask medically relevant questions. I later obtained a PhD at the University of Bergen in Norway and am currently a Senior Researcher at the Norwegian Institute of Public health. I am currently the primary investigator (PI) of the InferCan project and collaborator on several other international projects with broad scientific range from Alzheimers disease to childhood cancer to population genetics. Previously, I have been an Assistant Clinical Professor at Tisch Cancer Institute and Department of Preventive Medicine Icahn School of Medicine at Mount Sinai (Mount Sinai Hospital in NY, NY) where I was co-investigator on several NIH-funded grants on World Trade Center and cancer. I was also an annual guest lecturer at Georgetown University, my Alma mater. My work on chronic disease epidemiology has led to visiting scientist positions at the International Agency for Cancer Research at the WHO and Columbia University Medical Center. As an undergraduate, I was the recipient of a scholarship at New York University for outstanding academic achievement.